See more. Know more. With Renasight.
- Leverages next-generation sequencing and other methodologies on more than 380 genes associated with kidney disease
- Identifies autosomal dominant, autosomal recessive, and X-linked disorders
- Reports out pathogenic and likely pathogenic variants that were selected by genetic experts to provide actionable information
- > 99% detection rates across the genes screened1
![OH_REN_Clinician_s1-moz OH_REN_Clinician_s1](https://www.natera.com/wp-content/uploads/2021/05/OH_REN_Clinician_s1-moz-1.jpg)
![resources-slider2 Built on evidence](https://www.natera.com/wp-content/uploads/2021/05/OH_REN_Clinician_s2.1-moz.jpg)
Built on evidence
A recent New England Journal of Medicine publication assessing the incidence of genetic disease in kidney disease population found ~1 in 10 patients have a genetic diagnosis.2
Pinpoint and plan
Testing at the molecular level offers deeper insights to help deliver individualized patient care. In 89% of patients with kidney disease, a genetic diagnosis had implications for clinical management.2
![resources-slider2 Pinpoint and plan](https://www.natera.com/wp-content/uploads/2021/05/OH_REN_Clinician_s2.2-moz.jpg)
Integrate Renasight for better patient care
![OH_REN_Clinician_s3.1](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.1.png)
Gain prognostic insight
![OH_REN_Clinician_s3.2](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.2.png)
Identify an etiology for patients with unknown cause of their kidney disease
![OH_REN_Clinician_s3.3](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.3.png)
Prescribe targeted therapies
![OH_REN_Clinician_s3.4](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.4.png)
Refer patients for extra-renal features
![OH_REN_Clinician_s3.5](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.5.png)
Test family members and offer genetic counseling
![OH_REN_Clinician_s3.6](/wp-content/uploads/2020/12/OH_REN_Clinician_s3.6.png)
Enroll patients in clinical trials
Learn more about Renasight: Clinician brochure
Commitment to affordability
We welcome all insurance plans and provide affordable testing through a variety of payment methods. Natera offers discounted self-pay pricing and financial assistance through our compassionate care program.
The Natera team is here to help you with any billing or reimbursement questions at +1 650.425.4005.
![Commitment to affordability](https://www.natera.com/wp-content/uploads/2021/04/Counselor_iStock-1207514066-moz.jpeg)
Request more information about Renasight
References
1Natera data on file
2Groopman EE, Marasa M, Cameron-Christie S et al. Diagnostic utility of exome sequencing for kidney disease. NEJM. 2018;doi:10.1056.